MedCity News

JANUARY 30, 2025

Phase 2 data for Cargo Therapeutics CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. The post Safety Risk Sinks Cargo Therapeutics Cancer Cell Therapy Prospect, Leading to 50% Staff Cut appeared first on MedCity News.

Prospecting 114

Prospecting Safety Leads Biopharma 114

pharmaphorum

JANUARY 30, 2025

UK Biobank study suggests someone's risk of premature ageing or cognitive decline could be predicted using a simple ECG reading supported by an AI

98

98

MedCity News

JANUARY 30, 2025

Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today! The post A Snapshot of Five Contenders to Combat Infectious Diseases in the Post-Pandemic Landscape appeared first on MedCity News.

Biopharma 104

Biopharma 104

PharmaTech

JANUARY 30, 2025

Pharmaceutical Technology sat down with Adam Sherlock, CEO of Qinecsa, to discuss the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.

Pharma 66

Pharma Pharmaceutical 66

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

MedCity News

JANUARY 30, 2025

As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly and accurately to improve their health and prognosis. The post Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer’s Disease appeared first on MedCity News.

Patients 97

Patients 97

European Pharmaceutical Review

JANUARY 30, 2025

Christophe Weber is set to retire as Chief Executive Officer (CEO) of Takeda in June 2026 after 12 years.Julie Kim, president of Takedas US Business Unit has been appointed as Webers successor. Weber is the companys current President, CEO and representative director. He joined Takeda as CEO in April 2014. Two months later in June, he transitioned to the role of president and representative director.

Competition 59

Competition Marketing Management Leads 59

Pharmacy Times

JANUARY 30, 2025

The drug is a selective NaV1.8 pain signal inhibitor and is the first new class of medication to treat acute pain in over 20 years.

FDA 66

FDA Medical 66

PharmaTech

JANUARY 30, 2025

Pharmaceutical Technology spoke with Andy Burns, vice president, MDI Business Development at Kindeva, about how sustainability requirements are impacting contract development and manufacturing organizations, specifically for the development and manufacture of inhalation drugs.

Manufacturing 65

Manufacturing Pharmaceutical 65

Pharmacy Times

JANUARY 30, 2025

Digoxen is the active ingredient found in the foxglove plant and is commonly used to treat heart failure.

61

61

Silver Line CRM

JANUARY 30, 2025

Reading time: 3 minutes The pharmaceutical and medtech industries are tackling some of the toughest challenges in healthcare, from improving patient care to navigating complex regulations. Salesforce Life Sciences Cloud is stepping in as a powerful tool to help these industries work smarter, not harder. By combining AI, real-time data, and advanced tools, Life Sciences Cloud creates new opportunities to modernize processes, and Mphasis Silverline is at the forefront of partners innovating on the

Pharma 52

Pharma Customer Relationship Management Patients Healthcare 52

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

PharmaTech

JANUARY 30, 2025

The reduction is expected to be substantially completed, the San Diego-based company said, in the second quarter of 2025.

59

59

Pharmaceutical Technology

JANUARY 30, 2025

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Medicine 59

Medicine 59

Pharmaceutical Commerce

JANUARY 30, 2025

The latest news for pharma industry insiders.

Pharma 59

Pharma Patients 59

Pharmaceutical Technology

JANUARY 30, 2025

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

59

59

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Quantified

JANUARY 30, 2025

AI was novel in pharma training in early 2024. In 2025, its everywhere. At LTENs last 24 webinars , half had AI in the title. However, not all AI solutions are created equal. Many are little more than chatbots or “thin wrappers”essentially fancy interfaces for ChatGPT or Claude. While these tools have their place, they dont fundamentally transform how sales teams learn, practice, and perform in the field.

Training 52

Training Sales Pharma Medical science 52

Pharmaceutical Technology

JANUARY 30, 2025

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for challenging cancers.

59

59

pharmaphorum

JANUARY 30, 2025

ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales, and Northern Ireland, but not in Scotland.

56

56

Pharmaceutical Technology

JANUARY 30, 2025

Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery approaches.

59

59

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

pharmaphorum

JANUARY 30, 2025

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.

56

56

Pharmacy Times

JANUARY 30, 2025

Children and adults with cancer have differing immune system responses, mutational burdens, and tissue microenvironments.

54

54

PharmExec

JANUARY 30, 2025

Q4 earnings for companies such as Johnson & Johnson, Teva, and Roche highlight the impact of significant innovations brought to market last year.

Marketing 52

Marketing Pharma 52

Pharmaceutical Commerce

JANUARY 30, 2025

Can monitoring these dispensed Rxs via online search behavior help predict future GLP-1 use in the United States?

Prescription 52

Prescription Management 52

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmExec

JANUARY 30, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

pharmaphorum

JANUARY 30, 2025

In a new pharmaphorum podcast with ZS Associates Sharon Karlsberg, principal and leader of oncology solutions, and Brandi Davis-Dusenbery, principal and partner, web editor Nicole Raleigh explores the potential for scaling advanced technologies in the biopharmaceutical industry.

52

52

PharmExec

JANUARY 30, 2025

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung cancer who are PD-1 checkpoint inhibitor resistant.

Patients 52

Patients 52

Pharmaceutical Commerce

JANUARY 30, 2025

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

Marketing 52

Marketing Pharmaceutical manufacturing Distribution Manufacturing 52

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

PharmExec

JANUARY 30, 2025

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

Marketing 52

Marketing Pharmaceutical manufacturing Distribution Manufacturing 52

Pharmaceutical Commerce

JANUARY 30, 2025

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.

Pharma 52

Pharma 52

PharmExec

JANUARY 30, 2025

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant depression.

Patients 52

Patients 52

PharmaVoice

JANUARY 30, 2025

“Are you supportive of these onesies?” Sen. Bernie Sanders asked Kennedy, pointing to infant clothing stamped with anti-vaccine slogans — and more from yesterday’s confirmation hearing.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients